The AMP-activated protein kinase alpha2 catalytic subunit controls whole-body insulin sensitivity.

AMP-activated protein kinase (AMPK) is viewed as a fuel sensor for glucose and lipid metabolism. To better understand the physiological role of AMPK, we generated a knockout mouse model in which the AMPKalpha2 catalytic subunit gene was inactivated. AMPKalpha2(-/-) mice presented high glucose levels in the fed period and during an oral glucose challenge associated with low insulin plasma levels. However, in isolated AMPKalpha2(-/-) pancreatic islets, glucose- and L-arginine-stimulated insulin secretion were not affected. AMPKalpha2(-/-) mice have reduced insulin-stimulated whole-body glucose utilization and muscle glycogen synthesis rates assessed in vivo by the hyperinsulinemic euglycemic clamp technique. Surprisingly, both parameters were not altered in mice expressing a dominant-negative mutant of AMPK in skeletal muscle. Furthermore, glucose transport was normal in incubated isolated AMPKalpha2(-/-) muscles. These data indicate that AMPKalpha2 in tissues other than skeletal muscles regulates insulin action. Concordantly, we found an increased daily urinary catecholamine excretion in AMPKalpha2(-/-) mice, suggesting altered function of the autonomic nervous system that could explain both the impaired insulin secretion and insulin sensitivity observed in vivo. Therefore, extramuscular AMPKalpha2 catalytic subunit is important for whole-body insulin action in vivo, probably through modulation of sympathetic nervous activity.

[1]  G. Paolisso,et al.  Opposite effects of short- and long-term fatty acid infusion on insulin secretion in healthy subjects , 1995, Diabetologia.

[2]  J. Girard,et al.  Excessive glucose production, rather than insulin resistance, accounts for hyperglycaemia in recent-onset streptozotocin-diabetic rats , 1995, Diabetologia.

[3]  Bernard Thorens,et al.  Heterogeneous metabolic adaptation of C57BL/6J mice to high-fat diet. , 2002, American journal of physiology. Endocrinology and metabolism.

[4]  Y. Hellsten,et al.  Glycogen-dependent effects of 5-aminoimidazole-4-carboxamide (AICA)-riboside on AMP-activated protein kinase and glycogen synthase activities in rat skeletal muscle. , 2002, Diabetes.

[5]  J. McGarry.  Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. , 2002, Diabetes.

[6]  D. Hardie,et al.  AMP‐activated protein kinase: the energy charge hypothesis revisited , 2001, BioEssays : news and reviews in molecular, cellular and developmental biology.

[7]  Margaret S. Wu,et al.  Role of AMP-activated protein kinase in mechanism of metformin action. , 2001, The Journal of clinical investigation.

[8]  L. Rossetti,et al.  Central melanocortin receptors regulate insulin action. , 2001, The Journal of clinical investigation.

[9]  A. Kowluru,et al.  Activation of acetyl-CoA carboxylase by a glutamate- and magnesium-sensitive protein phosphatase in the islet beta-cell. , 2001, Diabetes.

[10]  M. Bucan,et al.  A role for AMP-activated protein kinase in contraction- and hypoxia-regulated glucose transport in skeletal muscle. , 2001, Molecular cell.

[11]  G. Shulman,et al.  Effect of 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside infusion on in vivo glucose and lipid metabolism in lean and obese Zucker rats. , 2001, Diabetes.

[12]  N. Fujii,et al.  AMP-activated protein kinase activity and glucose uptake in rat skeletal muscle. , 2001, American journal of physiology. Endocrinology and metabolism.

[13]  S. Vaulont,et al.  Cre-mediated germline mosaicism: a method allowing rapid generation of several alleles of a target gene. , 2000, Nucleic acids research.

[14]  R. Burcelin,et al.  Portal glucose infusion in the mouse induces hypoglycemia: evidence that the hepatoportal glucose sensor stimulates glucose utilization. , 2000, Diabetes.

[15]  K. Nonogaki,et al.  New insights into sympathetic regulation of glucose and fat metabolism , 2000, Diabetologia.

[16]  G. Shulman,et al.  Effect of AMPK activation on muscle glucose metabolism in conscious rats. , 1999, American journal of physiology. Endocrinology and metabolism.

[17]  B. Kemp,et al.  Cellular Distribution and Developmental Expression of AMP‐Activated Protein Kinase Isoforms in Mouse Central Nervous System , 1999, Journal of neurochemistry.

[18]  M. Yanagisawa,et al.  ETB receptor activation leads to activation and phosphorylation of NHE3. , 1999, American journal of physiology. Cell physiology.

[19]  D. Hardie,et al.  AMP-activated protein kinase is activated by low glucose in cell lines derived from pancreatic beta cells, and may regulate insulin release. , 1998, The Biochemical journal.

[20]  Tatsuya Hayashi,et al.  Evidence for 5′AMP-Activated Protein Kinase Mediation of the Effect of Muscle Contraction on Glucose Transport , 1998, Diabetes.

[21]  D. Drucker,et al.  Mouse pancreatic beta-cells exhibit preserved glucose competence after disruption of the glucagon-like peptide-1 receptor gene. , 1998, Diabetes.

[22]  R. Burcelin,et al.  Acute stimulation of glucose metabolism in mice by leptin treatment , 1997, Nature.

[23]  C. Newgard,et al.  β-Cell Function in Normal Rats Made Chronically Hyperleptinemic by Adenovirus-Leptin Gene Therapy , 1997, Diabetes.

[24]  A. Mark,et al.  Receptor-mediated regional sympathetic nerve activation by leptin. , 1997, The Journal of clinical investigation.

[25]  B. Kemp,et al.  Contraction-induced Changes in Acetyl-CoA Carboxylase and 5′-AMP-activated Kinase in Skeletal Muscle* , 1997, The Journal of Biological Chemistry.

[26]  S. Hawley,et al.  Characterization of the AMP-activated Protein Kinase Kinase from Rat Liver and Identification of Threonine 172 as the Major Site at Which It Phosphorylates AMP-activated Protein Kinase* , 1996, The Journal of Biological Chemistry.

[27]  N. Barzilai,et al.  Quantitation of hepatic glucose fluxes and pathways of hepatic glycogen synthesis in conscious mice. , 1995, The American journal of physiology.

[28]  S. Hawley,et al.  5-aminoimidazole-4-carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells? , 1995, European journal of biochemistry.

[29]  D. Hardie,et al.  5-aminoimidazole-4-carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells? , 1995, European journal of biochemistry.

[30]  D. Carling,et al.  Inhibition of lipolysis and lipogenesis in isolated rat adipocytes with AICAR, a cell‐permeable activator of AMP‐activated protein kinase , 1994, FEBS letters.

[31]  Yun-ping Zhou,et al.  Long-term exposure of rat pancreatic islets to fatty acids inhibits glucose-induced insulin secretion and biosynthesis through a glucose fatty acid cycle. , 1994, The Journal of clinical investigation.

[32]  M. Vincent,et al.  Inhibition by AICA Riboside of Gluconeogenesis in Isolated Rat Hepatocytes , 1991, Diabetes.

[33]  M. Berthault,et al.  Effects of counterregulatory hormones on insulin-induced glucose utilization by individual tissues in rats. , 1991, Diabete & metabolisme.

[34]  D. Pipeleers,et al.  Differences in adrenergic recognition by pancreatic A and B cells. , 1986, Science.

[35]  Y. Oomura,et al.  Lesions of the ventromedial hypothalamic nucleus enhance sympatho-adrenal function , 1985, Brain Research.

[36]  J. Chiasson,et al.  Inhibitory effect of epinephrine on insulin-stimulated glucose uptake by rat skeletal muscle. , 1981, The Journal of clinical investigation.

[37]  J. Exton.  Mechanisms involved in alpha-adrenergic phenomena: role of calcium ions in actions of catecholamines in liver and other tissues. , 1980, The American journal of physiology.